Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 09.03.2022.

#cleantech
#biotech
#ThePowerLaw
#PharmaDays
#startups

Startups

@NSInnoVentures shared
On Mar 3, 2022
We appreciate the continued support and leadership in strengthening our lifescience community here in Metro-North. https://t.co/SWg2GWAZAl #cleantech #biotech @MLSC @cummingsdotcom
Open
Baker-Polito Administration and Massachusetts Life Sciences Center announce $28.3 million in capital funding to support high demand innovation...

Baker-Polito Administration and Massachusetts Life Sciences Center announce $28.3 million in capital funding to support high demand innovation...

10 projects receiving funding through Life Sciences Center’s Research Infrastructure program with matching funds totaling more than $50 million Today, the Baker-Polito Administration and ...

@BusinessInsider shared
On Mar 3, 2022
RT @meliarobin: I learned an embarrassing amount about venture capital reading journalist @scmallaby's #ThePowerLaw. Highly recommend to anyone who wants to understand how venture works, and the players who shaped it. Here are the highlights, as promised 😉 https://t.co/0Squ5kcDbr
Open
11 key takeaways from 'The Power Law,' one of the best books on venture capital ever written

11 key takeaways from 'The Power Law,' one of the best books on venture capital ever written

Investors from Paul Graham to Deena Shakir are reading "The Power Law," a deeply researched history of venture capital.

@LifeSciVC shared
On Mar 3, 2022
RT @atlasventure: We are thrilled to continue working alongside talented entrepreneurs to build breakthrough biotech startups via our new $450M Atlas Venture Fund XIII https://t.co/vUbJVL1fh2 https://t.co/zyj54Pyjil
Open
Atlas Venture Announces $450 Million Fund XIII

Atlas Venture Announces $450 Million Fund XIII

Atlas Venture announces the closing of Atlas Venture Fund XIII, a $450M fund to invest in breakthrough biotech company creation.

@BusinessInsider shared
On Mar 7, 2022
RT @CannabisInsider: Psychedelics are closer than ever to coming to market. Here’s what the most influential women in the space think about the future of the industry. 👇 https://t.co/C9bzJiudcl
Open
The most influential women in psychedelics share how tech innovation, funding shifts, and biotech failures will shape the industry's rise

The most influential women in psychedelics share how tech innovation, funding shifts, and biotech failures will shape the industry's rise

Oregon is set to become the first US state to legalize magic mushrooms, potentially unlocking a market for psychedelic treatments.

@MALifeSciences shared
On Mar 5, 2022
RT @WBJournal: Two Worcester institutions received more than $5 million in grants from the Massachusetts Life Sciences Center, which on Thursday announced $28.3 million in capital funding to institutions across the state. https://t.co/LjId6yGqY2
Open
MBI, UMass Chan granted $5M for life sciences infrastructure

MBI, UMass Chan granted $5M for life sciences infrastructure

Two Worcester institutions received more than $5 million in grants from the Massachusetts Life Sciences Center, which on Thursday announced $28.3 million in capital funding to institutions ...

@paulg shared
On Mar 6, 2022
@AndyBeard Posterous would have done quite well on both counts. In fact Jessica still uses its successor, Posthaven. https://t.co/9NW1b37ivC
Open
Jessica Livingston

Jessica Livingston

Jessica Livingston

@MassBio shared
On Mar 8, 2022
Ahead of their #PharmaDays event on 4/5, learn about @Astellas_US approach to R&D strategy and collaboration from Head of Partnering Michael Luther. Read the full Q&A and learn more about the event on our blog: https://t.co/nKnRcxEPWU
Open
A Q&A with Astellas Pharma

A Q&A with Astellas Pharma

test

@BentheFidler shared
On Mar 3, 2022
Amid biotech downturn, Atlas raises $450M to build new drug #startups https://t.co/3MrfJLJxqQ by @NedPagliarulo @atlasventure $VIGL
Open
Amid biotech downturn, Atlas raises $450M to build new drug startups

Amid biotech downturn, Atlas raises $450M to build new drug startups

While a stock market slide has made IPOs difficult for young biotech companies, venture capital firms like Atlas are still reloading with new cash to create and invest in new drugmakers.

Read more: Startups
weekly 09.03.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy